SCHEMBL148468

SCHEMBL148468

O=C(Nc1cccnc1)c1cccc2c1[nH]c1ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
MEN1 O00255 1/20 0.58
HPGD P15428 1/20 0.58
KMT2A Q03164 1/20 0.58
CYP11B2 P19099 2/20 0.56
HSD17B10 Q99714 3/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
IDO1 P14902 1/20 0.54
POLB P06746 1/20 0.53
TSHR P16473 1/20 0.53
NAMPT P43490 3/20 0.51
MAPK1 P28482 1/20 0.51
LMNA P02545 4/20 0.50
PARP14 Q460N5 1/20 0.50
GAA P10253 1/20 0.50
CYP11B1 P15538 1/20 0.49
HIF1A Q16665 1/20 0.49
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833155 0.80 CNR1 (0.47) ALDH1A1KDM4EMEN1KMT2ANPC1
SCHEMBL4241048 0.78 HTR2C (0.70) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL677656 0.78 KMT2A (0.53) ALDH1A1KDM4EMEN1KMT2ANPC1
SCHEMBL6755653 0.78 ICOSLG (0.50) KDM4EMEN1KMT2ANPC1RAB9A
SCHEMBL6756686 0.77 KDR (0.48) MEN1KMT2A
SCHEMBL6759744 0.76 HTR2C (0.72)
SCHEMBL148606 0.76 PABPC1 (0.65) ALDH1A1KDM4EMEN1KMT2ALMNA
SCHEMBL6809571 0.75 KMT2A (0.49) ALDH1A1KDM4EMEN1KMT2ANPC1
SCHEMBL12029449 0.75 CYP11B2 (0.57) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL397919 0.75 CFTR (0.74) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
US-8084620-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-12-27 US disclosed
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 ALDH1A1 3832/4885KDM4E 733/4885MEN1 3158/4885
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 ALDH1A1 3832/4885KDM4E 733/4885MEN1 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.